We use cookies to optimize our website. These include cookies that are necessary for the operation of the site, as well as those that are only used for anonymous statistic. You can decide for yourself which categories you want to allow. Further information can be found in our data privacy protection .

Essential enable/disable

These cookies are necessary to run the core functionalities of this website and cannot be disabled.

Name	Webedition CMS
Purpose	This cookie is required by the CMS (Content Management System) Webedition for the system to function correctly. Typically, this cookie is deleted when the browser is closed.
Name	econda
Purpose	Session cookie emos_jcsid for the web analysis software econda. This runs in the “anonymized measurement” mode. There is no personal reference. As soon as the user leaves the site, tracking is ended and all data in the browser are automatically deleted.

Statistics enable/disable

These cookies help us understand how visitors interact with our website by collecting and analyzing information anonymously. Depending on the tool, one or more cookies are set by the provider.

Name	econda
Purpose	Statistics

External media enable/disable

Content from external media platforms is blocked by default. If cookies from external media are accepted, access to this content no longer requires manual consent.

Name	YouTube
Purpose	Show YouTube content
Name	Twitter
Purpose	activate Twitter Feeds

Research

Prof. Dr. Mathias Heikenwälder

Position:

Division Head

Affiliation:

Chronic Inflammation and Cancer (F180)

Contact:

Contact Form

Phone:

+49 6221 42-3891

Prof. Heikenwälder (*1976) and his group investigate the molecular and cellular mechanisms that lead to chronic inflammation, tissue damage, cancer and metastasis. In tight collaboration with clinics he is working on new models and therapy approaches. Prof. Heikenwälder studied microbiology in Vienna. After a two-year-research trip at the Max-Delbrück-Zentrum for medicine in Berlin graduated 1999 with highest honors. He started his doctoral thesis at the institute of neuropathology in Zurich and successfully graduated 2004 on the field of prion diseases. After his habilitation at the medical faculty oft he Universitätsspital Zürich he received 2007 a Max-Cloëtta-Professorship and started his work as a group leader with the research focus on "inflammation and cancer". In the year 2010he became junior professor at the TUM as well as group leader at the institute for virology at the Helmholtz Zentrum in Munich. Since 2015 Prof. Heikenwälder is group leader in the division F180 „chronic inflammation and cancer" at the German Cancer Research Centre in Heidelberg.

Major Commendations

ERC Consolidator Grant (2016)
Walther und Christine Ritzenhain-Preis (2012)
ERC Starting Grant (2010)
Hans-Peter Hofschneider-Preis (2010)
Götz-Preis, vergeben an der Universität Zürich, Schweiz (2009)
Max-Cloëtta Professorship (2007)
EMPIRIS Award (2006)
Creutzfeld-Preis (2004)

Team

Open positions